MREO | Mereo BioPharma Group plc Annual & Quarterly

Annual Balance Sheets

(In USD)

Breakdown	2023	2022	2021	2020	2019	2018
Total Assets	66.49 Million	88.07 Million	126.41 Million	62.94 Million	86.44 Million	67.27 Million
Total Current Assets	63.76 Million	62.13 Million	99.32 Million	29.72 Million	30.43 Million	34.49 Million
Cash And Short Term Investments	57.42 Million	56.33 Million	94.29 Million	23.46 Million	16.34 Million	27.54 Million
Cash and Cash Equivalents	57.42 Million	56.33 Million	94.29 Million	23.46 Million	16.34 Million	25.04 Million
Short Term Investments	-	51.1 Million	569 Thousand	547 Thousand	544 Thousand	2.5 Million
Net Receivables	3.73 Million	2.67 Million	1.82 Million	4.63 Million	11.97 Million	5.88 Million
Inventory	1.24 Million	-2.67 Million	-1.81 Million	-4.63 Million	-11.97 Million	-293.32 Thousand
Other Current Assets	1.36 Million	5.79 Million	5.02 Million	6.25 Million	14.08 Million	1.36 Million
Total Non-Current Assets	2.73 Million	25.94 Million	27.09 Million	33.22 Million	56.01 Million	32.78 Million
Net PPE	1.65 Million	1.83 Million	2.53 Million	1.57 Million	11.55 Million	148.93 Thousand
Good Will And Intangible Assets	1.08 Million	24.11 Million	24.56 Million	31.64 Million	44.45 Million	32.63 Million
Good Will	-	-	-	-	-	-
Intangible Assets	1.08 Million	24.11 Million	24.56 Million	31.64 Million	44.45 Million	32.63 Million
Long-Term Investments	-	-	-	-	-	-
Tax Assets	-	-	-	-	-	-
Other Non Current Assets	-	-25.94 Million	-27.09 Million	-33.22 Million	-56.01 Million	-
Other Assets	-	-0.00	-	-	-	-
Total Liabilities	15.96 Million	26.21 Million	38.41 Million	77.91 Million	46.19 Million	34.5 Million
Total Current Liabilities	9.48 Million	24.67 Million	12.54 Million	8.56 Million	29.87 Million	16.17 Million
Account Payables	2.34 Million	3.07 Million	2.28 Million	3.33 Million	6.35 Million	4.57 Million
Tax Payables	662 Thousand	167 Thousand	1.71 Million	146 Thousand	183 Thousand	160.71 Thousand
Short Term Debt	652 Thousand	11.55 Million	622 Thousand	636 Thousand	17.72 Million	6.83 Million
Deferred Revenue	6.45 Million	-	8.36 Million	-	5.44 Million	-177.7 Thousand
Other Current Liabilities	30 Thousand	10.04 Million	1.26 Million	4.59 Million	354 Thousand	4.94 Million
Total Non Current Liabilities	6.47 Million	1.53 Million	25.87 Million	69.35 Million	16.31 Million	18.32 Million
Long-Term Debt	5.3 Million	1.22 Million	16.13 Million	17.3 Million	14.69 Million	14.64 Million
Deferred Revenue Non Current	-	-	-	-	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	1.17 Million	311 Thousand	9.73 Million	52.05 Million	1.62 Million	3.68 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	50.53 Million	61.86 Million	88 Million	-14.97 Million	40.25 Million	32.77 Million
Stock Holders Equity	50.53 Million	61.86 Million	88 Million	-14.97 Million	40.25 Million	32.77 Million
Common Stock	2.77 Million	1.87 Million	1.75 Million	1.01 Million	294 Thousand	213.72 Thousand
Retained Earnings	-419.63 Million	-331.16 Million	-296.96 Million	-309.69 Million	-146.06 Million	-111.22 Million
Accumulated other comprehensive income	-17.48 Million	137.91 Million	136.89 Million	133.22 Million	47.31 Million	25.59 Million
Common Stock Equity	50.53 Million	61.86 Million	88 Million	-14.97 Million	40.25 Million	32.77 Million
Capital Lease Obligation	1.55 Million	1.68 Million	2.37 Million	1.79 Million	11.9 Million	-
Total Investments	-	51.1 Million	569 Thousand	547 Thousand	544 Thousand	2.5 Million
Total Debt	5.95 Million	12.77 Million	16.76 Million	17.93 Million	32.41 Million	21.48 Million
Net Debt	-51.46 Million	-43.56 Million	-77.53 Million	-5.53 Million	16.06 Million	-3.55 Million

Breakdown	2024 Q2	2024 Q1	2023 FY	2023 Q4	2023 Q3	2023 Q2
Total Assets	96.12 Million	55.93 Million	66.49 Million	66.49 Million	54.5 Million	80.63 Million
Total Current Assets	93.94 Million	53.49 Million	63.76 Million	63.76 Million	52.26 Million	54.22 Million
Cash And Short Term Investments	87.43 Million	48.66 Million	57.42 Million	57.42 Million	47.06 Million	42.11 Million
Cash and Cash Equivalents	87.43 Million	48.66 Million	57.42 Million	57.42 Million	47.06 Million	42.11 Million
Short Term Investments	-	-	-	-	-	-
Net Receivables	2.67 Million	2.15 Million	3.73 Million	3.73 Million	-	10.73 Million
Inventory	1.00	1.82 Million	1.24 Million	1.24 Million	-	-2.84 Million
Other Current Assets	3.83 Million	864 Thousand	1.36 Million	1.36 Million	5.19 Million	4.22 Million
Total Non-Current Assets	2.18 Million	2.44 Million	2.73 Million	2.73 Million	2.24 Million	26.41 Million
Net PPE	1.32 Million	1.46 Million	1.65 Million	1.65 Million	1.35 Million	1.56 Million
Good Will And Intangible Assets	866 Thousand	972 Thousand	1.08 Million	1.08 Million	892.6 Thousand	24.84 Million
Good Will	-	-	-	-	-	-
Intangible Assets	866 Thousand	972 Thousand	1.08 Million	1.08 Million	892.6 Thousand	24.84 Million
Long-Term Investments	-	-	-	-	-	-
Tax Assets	-	-	-	-	-	-
Other Non Current Assets	-	-	-	-	1.00	1000.00
Other Assets	-	-	-	-	-	-
Total Liabilities	17.47 Million	13.09 Million	15.96 Million	15.96 Million	13.08 Million	22.89 Million
Total Current Liabilities	15.46 Million	11 Million	9.48 Million	9.48 Million	7.77 Million	17.45 Million
Account Payables	2.7 Million	2.45 Million	2.34 Million	2.34 Million	1.92 Million	1.91 Million
Tax Payables	2.29 Million	391 Thousand	662 Thousand	662 Thousand	-	-
Short Term Debt	5.61 Million	5.29 Million	652 Thousand	652 Thousand	-	4.67 Million
Deferred Revenue	-	3.22 Million	6.45 Million	6.45 Million	-	9.48 Million
Other Current Liabilities	7.15 Million	37 Thousand	30 Thousand	30 Thousand	5.85 Million	1.38 Million
Total Non Current Liabilities	2.01 Million	2.09 Million	6.47 Million	6.47 Million	5.3 Million	5.43 Million
Long-Term Debt	552 Thousand	727 Thousand	5.3 Million	5.3 Million	4.34 Million	4.63 Million
Deferred Revenue Non Current	-	-	-	-	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	1.46 Million	1.36 Million	1.17 Million	1.17 Million	963.92 Thousand	797 Thousand
Other Liabilities	-	-	-	-	-	-
Total Equity	78.64 Million	42.83 Million	50.53 Million	50.53 Million	41.42 Million	57.74 Million
Stock Holders Equity	78.64 Million	42.83 Million	50.53 Million	50.53 Million	41.42 Million	57.74 Million
Common Stock	3.03 Million	2.77 Million	2.77 Million	2.77 Million	2.27 Million	1.93 Million
Retained Earnings	-440.83 Million	-428.58 Million	-419.63 Million	-419.63 Million	-343.95 Million	-342.19 Million
Accumulated other comprehensive income	-18.27 Million	-18.28 Million	-17.48 Million	-17.48 Million	-14.33 Million	141.72 Million
Common Stock Equity	78.64 Million	42.83 Million	50.53 Million	50.53 Million	41.42 Million	57.74 Million
Capital Lease Obligation	552 Thousand	1.38 Million	1.55 Million	1.55 Million	1.27 Million	1.46 Million
Total Investments	-	-	-	-	-	-
Total Debt	6.16 Million	6.01 Million	5.95 Million	5.95 Million	4.34 Million	9.31 Million
Net Debt	-81.26 Million	-42.64 Million	-51.46 Million	-51.46 Million	-42.72 Million	-32.8 Million

Balance Sheet Charts

The Charles Schwab Corporation

SCHW

Full Analysis

Annual Balance Sheets
Johnson Controls-Hitachi Air Conditioning India Limited

JCHAC

Full Analysis

Annual Balance Sheets
Saregama India Limited

SAREGAMA

Full Analysis

Annual Balance Sheets
Zhejiang Xinhua Chemical Co.,Ltd

603867

Full Analysis

Annual Balance Sheets
CMC Corporation

2185

Full Analysis

Annual Balance Sheets
DICK'S Sporting Goods, Inc.

DKS

Full Analysis

Annual Balance Sheets

Global Stocks Search

Mereo BioPharma Group plc (MREO)

Annual Balance Sheets

Balance Sheet Charts

The Charles Schwab Corporation

Johnson Controls-Hitachi Air Conditioning India Limited

Saregama India Limited

Zhejiang Xinhua Chemical Co.,Ltd

CMC Corporation

DICK'S Sporting Goods, Inc.